CareCloud, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CCLD research report →
Range $3 – $3.25
Price Chart
About the company
CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States.
- CEO
- Stephen A. Snyder
- IPO
- 2014
- Employees
- 3,650
- HQ
- Somerset, NJ, US
Get TickerSpark's AI analysis on CCLD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $85.95M
- P/E
- 17.87
- Fwd P/E
- 13.03
- PEG
- 0.08
- P/S
- 0.75
- P/B
- 4.36
- EV/EBITDA
- 4.43
- Div Yield
- 0.00%
- Gross Margin
- 32.75%
- Op Margin
- 9.70%
- Net Margin
- 7.36%
- ROE
- 24.48%
- ROIC
- 18.41%
Latest fiscal year · YoY change
- Revenue
- $120.50M+8.7%
- Gross Profit
- $56.04M+12.1%
- Op Income
- $11.50M
- Net Income
- $10.80M+37.5%
- EPS
- $0.09+132.8%
- OCF Growth
- +38.4%
- FCF Growth
- +8.4%
- 52W High
- $3.81
- 52W Low
- $1.67
- 50D MA
- $2.05
- 200D MA
- $2.45
- Beta
- 1.56
- RSI (14)
- 45
- Avg Volume
- 419.26K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CareCloud posted its most profitable quarter ever, with record GAAP net income, EPS and adjusted EBITDA, while reaffirming full-year guidance and highlighting AI-led margin gains and a cleaner capital structure.· November 5, 2026
- Third quarter revenue was $33.7 million, up 9% year over year, with gross margin expanding to 50.5% from 47.8%.
- GAAP net income hit a record $4.7 million, up 54% year over year, and GAAP EPS was $0.10 versus $0.04.
- Adjusted EBITDA reached a record $9.9 million, up 28% year over year, and adjusted EBITDA margin was about 29% versus 25%.
- Preferred dividends fell sharply after the capital structure reset, leaving about 89%-90% of net income attributable to common shareholders versus about 55% a year ago.
- Management reaffirmed full-year 2026 guidance for revenue of $128 million to $132 million, adjusted EBITDA of $29 million to $31 million, and GAAP EPS of $0.20 to $0.23.
CareCloud reported third quarter revenue of $33.7 million, up 9% year over year, and first 9-month revenue of $96.9 million, up 13%. GAAP net income was a record $4.7 million, up 54% year over year, and GAAP EPS was a record $0.10 versus $0.04. Adjusted EBITDA was a record $9.9 million, up 28% year over year, with adjusted EBITDA margin at about 29% versus 25% last year. Gross margin expanded to 50.5% from 47.8%. For the full year, management reaffirmed guidance for revenue of $128 million to $132 million, adjusted EBITDA of $29 million to $31 million, and GAAP EPS of $0.20 to $0.23.
Stephen Snyder said the quarter showed CareCloud’s deliberate tradeoff to build durable earnings power was paying off, with AI and automation, expense discipline and a better mix of higher-margin offerings driving margin expansion. He emphasized that the capital structure overhaul is now benefiting common shareholders directly, with preferred dividends reduced to about $540,000 this quarter from roughly $15 million annually two years ago. He also framed enterprise AI development and compliance as the next growth engines, citing KabaFusion/LailaCare and Empower as examples of repeatable opportunities.
Bonnie Boyer focused on the mechanics behind the margin improvement: revenue rose about 9% while direct operating costs rose only 3%, and total operating expenses declined 2.5% to $27.2 million. She said adjusted EBITDA rose 28% to $9.9 million and net income was $4.7 million, while net interest expense was about $1.7 million, including $934,000 of non-cash financing-related expense tied to warrants. She also highlighted balance sheet improvement, noting $4.6 million of cash, about $37.3 million of total debt, net debt of $32.7 million, and a net leverage ratio of about 1.1x trailing 12-month adjusted EBITDA; the revolver was fully repaid and $10 million is available there.
Analysts pressed management on whether Medsphere can expand beyond its current contribution and how much room there is to grow through existing customers and new wins; management said most integration work is done and sees near-term upside from wallet-share expansion, AI add-ons, and critical access/small hospital opportunities. Questions on Empower focused on how the business can identify overpayments and translate compliance work into growth; management said it often starts with a payer-identified audit problem, then supports appeals and documentation, and that successful compliance work has already led to new RCM relationships. Analysts also probed expenses and fourth-quarter seasonality, and management said operating costs should stay disciplined but that Q4 is still seasonally softer, so they would not simply annualize the quarter.
The call showed tangible evidence that CareCloud’s AI and automation investments are lowering manual work and supporting higher margins, with manual claim touches down about 44% and denial rates below 4%. Management also pointed to a cleaner capital structure, lower preferred obligations and debt paydown as reasons more of each dollar should now accrue to common shareholders. New initiatives like LailaCare and a planned compliance SaaS offering suggest additional revenue streams on top of the recurring base.
Management acknowledged seasonal softness in the fourth quarter and first quarter, so the recent profit run rate may not be linear. They also said the outlook depends on client/vendor relationships, project timing and execution of integration and expense initiatives. Finally, parts of the business still depend on ongoing acquisitions and new product launches scaling successfully, while the remaining Series A preferred stock is still under evaluation.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 60.0%
- Shares Outstanding
- 42.55M
- Float Shares
- 25.53M
of shares held by institutions
72 13F filers
Buy/sell ratio 2.25. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CCLD, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Kevin HernHouse · OK01 | Sell | Dec 19, 22 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Capital Management LLC | 1.68M | 0 |
| Vanguard Group Inc | 1.66M | ▲ 486.42K |
| Hillsdale Investment Management Inc. | 916.21K | ▼ 7.20K |
| Dimensional Fund Advisors LP | 665.11K | ▲ 89.14K |
| Two Sigma Investments, LP | 588.93K | ▲ 9.10K |
| American Century Companies Inc | 491.58K | ▼ 18.12K |
| Bridgeway Capital Management, LLC | 429.53K | ▲ 20.27K |
| Geode Capital Management, LLC | 396.08K | ▼ 25.50K |
| Wells Fargo & Company/Mn | 385.00K | 0 |
| Globeflex Capital L P | 335.15K | 0 |
| Arrowstreet Capital, Limited Partnership | 322.88K | ▼ 11.93K |
| Ameriprise Financial Inc | 229.27K | ▼ 212.38K |
Held by 43 ETFs
Biggest fund positions in CCLD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Boyer Bonnie Alice | other | 0 |
| Aug 8, 26 | BUSQUET ANNE | other | 7,500 |
| Aug 8, 26 | BUSQUET ANNE | other | 7,500 |
| Aug 8, 26 | KORN BILL | other | 7,500 |
| Aug 8, 26 | KORN BILL | other | 7,500 |
| Aug 8, 26 | MUNTER CAMERON | other | 7,500 |
| Aug 8, 26 | MUNTER CAMERON | other | 7,500 |
| Aug 8, 26 | Sharnak Lawrence Steven | other | 7,500 |
| Aug 8, 26 | Sharnak Lawrence Steven | other | 7,500 |
| Jul 31, 26 | MUNTER CAMERON | other | 6,250 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CCLD coverage
Recent articles, reports, and earnings notes.
No research on CCLD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CCLD report →Head-To-Head Survey: OptimizeRx (NASDAQ:OPRX) vs. CareCloud (NASDAQ:CCLD)
defenseworld.net · Nov 19
CareCloud Accelerates AI-Powered Growth with Over 40% Reduction in Claim Denials and Multiple New RCM Wins
globenewswire.com · Nov 18
CareCloud Accelerates Wound Care Expansion with New Clients, EHR Integration and Multimillion-Dollar Payer Client Audit Wins
globenewswire.com · Nov 11
CareCloud, Inc. (CCLD) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
What CareCloud (CCLD) Said on Its Q3 Earnings Call
marketbeat.com · Nov 5
CareCloud, Inc. (CCLD) Tops Q3 Earnings and Revenue Estimates
zacks.com · Nov 5
CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA
globenewswire.com · Nov 5
CareCloud Appoints Mitchell Brie as Chief Compliance Officer to Support Compliance Services Growth
globenewswire.com · Oct 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.